SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Interim Management Statement

14 Nov 2013 07:00

RNS Number : 9770S
Devro PLC
14 November 2013
 



For immediate release

14 November 2013

 

 

Devro plc

("the Group")

 

Interim Management Statement

 

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today provides an Interim Management Statement covering the period from 1 July 2013 to date.

 

Revenue continued to grow helped by the full impact of price increases implemented in the first half with sales volumes unchanged against the same period last year. Trading profits and margins have improved in the second half as new capacity at the Czech plant has come on stream.

Sales have been strong in emerging markets, most notably Latin America, China and South East Asia. Germany and Japan continued to grow volumes across all major product categories. Developed markets such as the UK, continental Europe, Australia and North America traded more slowly than prior year and below our expectations.

Select, the innovative thin walled casing introduced in 2010 to replace top quality sheep gut, continues to make a significant contribution to sales. In the year to date Select accounts for 8% of all sales in the Group. There continue to be good opportunities for new sales.

Manufacturing operations ran well with the investment at the Czech plant now complete and production at full capacity.

The Board has approved capital expenditure to construct a new manufacturing hall at our site in South Carolina, USA. This £40m project, which will be funded from the Group's existing facilities and future cash flow, will enable the business to reduce manufacturing costs by c.£8m pa from 2016 onwards, with full benefits expected in 2017. This investment is part of our continuing manufacturing improvement programme which will further enhance profits for sales into the Americas.

As mentioned at the interims, the Group is actively evaluating options for expansion of capacity through an investment in China and we expect to report on this in early 2014.

Hide prices are higher than the prior year although the rate of increase has significantly slowed compared with the increases experienced in the last 18 months.

The Japanese yen has devalued by 20% against prior year although the impact on 2013 has been minimised through forward hedging. In 2014, based on current exchange rates, we estimate that profits will be adversely affected by approximately £3m as current hedging arrangements unwind.

Gross debt is broadly in line with the level at the half year and continues to be well within the banking facilities.

 

Outlook

 

In light of unchanged sales volumes and weakness in some developed markets since 1st July, the Board now expects the outcome for 2013 to be towards the lower end of market expectations.

 

The Board remains confident in the longer term opportunities for supplying a dynamic and growing global market for edible casings.

 

For further information, please contact:

Devro plc

 

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

Tel No: 0207 182 4960

 

Buchanan

 

Charles Ryland / Sophie McNulty / Clare Akhurst

 

 

Tel No: 020 7466 5000

Further information on Devro can be found on the company's website: www.devro.com

As previously announced, Devro will be holding an investor presentation to provide an update on the Group's investment programme today at 4.00pm. The presentation will be available on the company's website shortly thereafter. No new material information will be disclosed during the presentation.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMMMMNFZGFZM
Date   Source Headline
7th Apr 20204:00 pmRNS2019 Annual Report and Notice of AGM
31st Mar 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSDirectorate Changes
9th Mar 20202:26 pmRNSHolding(s) in Company
6th Mar 20205:10 pmRNSDirector/PDMR Shareholding
6th Mar 202012:11 pmRNSDirector/PDMR Shareholding
6th Mar 202012:11 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSFull Year Results
17th Jan 20207:00 amRNSTrading Update
12th Dec 20198:42 amRNSDirector Declaration
25th Oct 20195:31 pmRNSDirector/PDMR Shareholding
24th Oct 201910:57 amRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSTrading Update & Manufacturing Footprint Review
10th Oct 201911:44 amRNSDirector/PDMR Shareholding
20th Sep 201912:59 pmRNSHolding(s) in Company
14th Aug 20191:45 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSHALF YEAR RESULTS
5th Jul 20191:17 pmRNSHolding(s) in Company
19th Jun 20197:00 amRNSHolding(s) in Company
15th May 20196:24 pmRNSDirector/PDMR Shareholding
14th May 20193:44 pmRNSDirector/PDMR Shareholding
7th May 20197:00 amRNSDirectorate Changes
2nd May 20193:28 pmRNSDirector/PDMR Shareholding
25th Apr 20194:04 pmRNSResult of AGM
25th Apr 20197:00 amRNSTrading Update
12th Apr 20191:08 pmRNSCompany Secretary change
11th Apr 201910:48 amRNSDirector/PDMR Shareholding
22nd Mar 20194:07 pmRNS2018 Annual Report and Notice of AGM
19th Mar 20192:00 pmRNSCapital Markets Event
6th Mar 20192:09 pmRNSDirector/PDMR Shareholding
6th Mar 20192:08 pmRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFull Year Results
20th Feb 20193:27 pmRNSHolding(s) in Company
14th Feb 201911:59 amRNSHolding(s) in Company
14th Feb 201911:34 amRNSDirector/PDMR Shareholding
23rd Jan 20193:02 pmRNSHolding(s) in Company
10th Dec 20184:05 pmRNSHolding(s) in Company
4th Dec 20184:46 pmRNSHolding(s) in Company
20th Nov 20183:33 pmRNSHolding(s) in Company
20th Nov 201811:51 amRNSHolding(s) in Company
19th Nov 20181:35 pmRNSDirector/PDMR Shareholding
19th Nov 20181:34 pmRNSDirector/PDMR Shareholding
16th Nov 201810:33 amRNSDirector/PDMR Shareholding
15th Nov 20187:00 amRNSRetirement of Chairman
15th Nov 20187:00 amRNSTrading Update
5th Nov 20181:49 pmRNSHolding(s) in Company
23rd Oct 20183:47 pmRNSHolding(s) in Company
15th Oct 20184:27 pmRNSDirector/PDMR Shareholding
18th Sep 201811:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.